Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business
CombiMatrix Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CombiMatrix Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2010-03-11 08:11:03 - CombiMatrix Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/combimatrix- ..

CombiMatrix Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

CombiMatrix Corporation (CombiMatrix), a biotechnology company is engaged in the development of products and services with its focus on genetic analysis, drug development, nanotechnology, molecular diagnostics, defense and homeland securities. The company has developed proprietary platform technologies to offer in-situ, oligonucleeotide arrays. These arrays are useful for the determination of gene mutations and proteins. Its proprietary technology also finds applications in bio sensors, genomics, proteomics, combinatorial chemistry,

 

 

nanotechnology, material science, drug discovery and development.

And More inside the report…

Recent Developments

Jan 25, 2010: CombiMatrix Appoints Mark McGowan To Its Board
Dec 21, 2009: CombiMatrix Announces Hearing Date Regarding Its $36 Million Judgment Against National Union
Nov 11, 2009: CombiMatrix Reports Q3 2009 Results

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings, partnerships and licensing agreements.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser